The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cytology and HPV Testing Market Research Report 2025
Synopsis
Cytology Testing, taking the exfoliated cells of the cervix and vagina to determine the possibility of cervical and vaginal precancerous lesions. And HPV Testing is to screen viruses, detect whether there is human papillomavirus in vaginal secretions, especially high-risk human papillomavirus; Cytology Testing has high specificity but poor sensitivity, HPV Testing has strong sensitivity but poor specificity; HPV Testing It can be used as an effective supplement to Cytology Testing, and the combined screening of the two is conducive to improving screening efficiency and increasing the accuracy of Hospitals & Clinics.
The global Cytology and HPV Testing market was valued at US$ 4069 million in 2023 and is anticipated to reach US$ 6755.5 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
Global key players of Cytology and HPV Testing include Thermo Fisher Scientific, Roche Diagnostics, QIAGEN, Bio-rad, etc. The top four players hold a share over 40%. North America is the largest market, has a share about 41%, followed by Europe, and Asia-Pacific, with share 26% and 22%, separately. In terms of product type, Consumables is the largest segment, occupied for a share of 58%, and in terms of application, Hospitals & Clinics has a share about 58%.
This report aims to provide a comprehensive presentation of the global market for Cytology and HPV Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cytology and HPV Testing.
Report Scope
The Cytology and HPV Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cytology and HPV Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cytology and HPV Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Roche Diagnostics
QIAGEN
Bio-rad
Hologic
BD
Hybribio
KingMed Diagnostics
Abbott
bioMérieux
Cepheid
BGI Group
Seegene
Daan Gene
Segment by Type
Instruments
Consumables
Services
Segment by Application
Hospitals & Clinics
Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cytology and HPV Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cytology Testing, taking the exfoliated cells of the cervix and vagina to determine the possibility of cervical and vaginal precancerous lesions. And HPV Testing is to screen viruses, detect whether there is human papillomavirus in vaginal secretions, especially high-risk human papillomavirus; Cytology Testing has high specificity but poor sensitivity, HPV Testing has strong sensitivity but poor specificity; HPV Testing It can be used as an effective supplement to Cytology Testing, and the combined screening of the two is conducive to improving screening efficiency and increasing the accuracy of Hospitals & Clinics.
The global Cytology and HPV Testing market was valued at US$ 4069 million in 2023 and is anticipated to reach US$ 6755.5 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
Global key players of Cytology and HPV Testing include Thermo Fisher Scientific, Roche Diagnostics, QIAGEN, Bio-rad, etc. The top four players hold a share over 40%. North America is the largest market, has a share about 41%, followed by Europe, and Asia-Pacific, with share 26% and 22%, separately. In terms of product type, Consumables is the largest segment, occupied for a share of 58%, and in terms of application, Hospitals & Clinics has a share about 58%.
This report aims to provide a comprehensive presentation of the global market for Cytology and HPV Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cytology and HPV Testing.
Report Scope
The Cytology and HPV Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cytology and HPV Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cytology and HPV Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Roche Diagnostics
QIAGEN
Bio-rad
Hologic
BD
Hybribio
KingMed Diagnostics
Abbott
bioMérieux
Cepheid
BGI Group
Seegene
Daan Gene
Segment by Type
Instruments
Consumables
Services
Segment by Application
Hospitals & Clinics
Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cytology and HPV Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cytology and HPV Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Instruments
1.2.3 Consumables
1.2.4 Services
1.3 Market by Application
1.3.1 Global Cytology and HPV Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals & Clinics
1.3.3 Laboratories
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cytology and HPV Testing Market Perspective (2019-2030)
2.2 Cytology and HPV Testing Growth Trends by Region
2.2.1 Global Cytology and HPV Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cytology and HPV Testing Historic Market Size by Region (2019-2024)
2.2.3 Cytology and HPV Testing Forecasted Market Size by Region (2025-2030)
2.3 Cytology and HPV Testing Market Dynamics
2.3.1 Cytology and HPV Testing Industry Trends
2.3.2 Cytology and HPV Testing Market Drivers
2.3.3 Cytology and HPV Testing Market Challenges
2.3.4 Cytology and HPV Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cytology and HPV Testing Players by Revenue
3.1.1 Global Top Cytology and HPV Testing Players by Revenue (2019-2024)
3.1.2 Global Cytology and HPV Testing Revenue Market Share by Players (2019-2024)
3.2 Global Cytology and HPV Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cytology and HPV Testing Revenue
3.4 Global Cytology and HPV Testing Market Concentration Ratio
3.4.1 Global Cytology and HPV Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cytology and HPV Testing Revenue in 2023
3.5 Cytology and HPV Testing Key Players Head office and Area Served
3.6 Key Players Cytology and HPV Testing Product Solution and Service
3.7 Date of Enter into Cytology and HPV Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cytology and HPV Testing Breakdown Data by Type
4.1 Global Cytology and HPV Testing Historic Market Size by Type (2019-2024)
4.2 Global Cytology and HPV Testing Forecasted Market Size by Type (2025-2030)
5 Cytology and HPV Testing Breakdown Data by Application
5.1 Global Cytology and HPV Testing Historic Market Size by Application (2019-2024)
5.2 Global Cytology and HPV Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cytology and HPV Testing Market Size (2019-2030)
6.2 North America Cytology and HPV Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cytology and HPV Testing Market Size by Country (2019-2024)
6.4 North America Cytology and HPV Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cytology and HPV Testing Market Size (2019-2030)
7.2 Europe Cytology and HPV Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cytology and HPV Testing Market Size by Country (2019-2024)
7.4 Europe Cytology and HPV Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cytology and HPV Testing Market Size (2019-2030)
8.2 Asia-Pacific Cytology and HPV Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cytology and HPV Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Cytology and HPV Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cytology and HPV Testing Market Size (2019-2030)
9.2 Latin America Cytology and HPV Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cytology and HPV Testing Market Size by Country (2019-2024)
9.4 Latin America Cytology and HPV Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cytology and HPV Testing Market Size (2019-2030)
10.2 Middle East & Africa Cytology and HPV Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cytology and HPV Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Cytology and HPV Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Cytology and HPV Testing Introduction
11.1.4 Thermo Fisher Scientific Revenue in Cytology and HPV Testing Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Detail
11.2.2 Roche Diagnostics Business Overview
11.2.3 Roche Diagnostics Cytology and HPV Testing Introduction
11.2.4 Roche Diagnostics Revenue in Cytology and HPV Testing Business (2019-2024)
11.2.5 Roche Diagnostics Recent Development
11.3 QIAGEN
11.3.1 QIAGEN Company Detail
11.3.2 QIAGEN Business Overview
11.3.3 QIAGEN Cytology and HPV Testing Introduction
11.3.4 QIAGEN Revenue in Cytology and HPV Testing Business (2019-2024)
11.3.5 QIAGEN Recent Development
11.4 Bio-rad
11.4.1 Bio-rad Company Detail
11.4.2 Bio-rad Business Overview
11.4.3 Bio-rad Cytology and HPV Testing Introduction
11.4.4 Bio-rad Revenue in Cytology and HPV Testing Business (2019-2024)
11.4.5 Bio-rad Recent Development
11.5 Hologic
11.5.1 Hologic Company Detail
11.5.2 Hologic Business Overview
11.5.3 Hologic Cytology and HPV Testing Introduction
11.5.4 Hologic Revenue in Cytology and HPV Testing Business (2019-2024)
11.5.5 Hologic Recent Development
11.6 BD
11.6.1 BD Company Detail
11.6.2 BD Business Overview
11.6.3 BD Cytology and HPV Testing Introduction
11.6.4 BD Revenue in Cytology and HPV Testing Business (2019-2024)
11.6.5 BD Recent Development
11.7 Hybribio
11.7.1 Hybribio Company Detail
11.7.2 Hybribio Business Overview
11.7.3 Hybribio Cytology and HPV Testing Introduction
11.7.4 Hybribio Revenue in Cytology and HPV Testing Business (2019-2024)
11.7.5 Hybribio Recent Development
11.8 KingMed Diagnostics
11.8.1 KingMed Diagnostics Company Detail
11.8.2 KingMed Diagnostics Business Overview
11.8.3 KingMed Diagnostics Cytology and HPV Testing Introduction
11.8.4 KingMed Diagnostics Revenue in Cytology and HPV Testing Business (2019-2024)
11.8.5 KingMed Diagnostics Recent Development
11.9 Abbott
11.9.1 Abbott Company Detail
11.9.2 Abbott Business Overview
11.9.3 Abbott Cytology and HPV Testing Introduction
11.9.4 Abbott Revenue in Cytology and HPV Testing Business (2019-2024)
11.9.5 Abbott Recent Development
11.10 bioMérieux
11.10.1 bioMérieux Company Detail
11.10.2 bioMérieux Business Overview
11.10.3 bioMérieux Cytology and HPV Testing Introduction
11.10.4 bioMérieux Revenue in Cytology and HPV Testing Business (2019-2024)
11.10.5 bioMérieux Recent Development
11.11 Cepheid
11.11.1 Cepheid Company Detail
11.11.2 Cepheid Business Overview
11.11.3 Cepheid Cytology and HPV Testing Introduction
11.11.4 Cepheid Revenue in Cytology and HPV Testing Business (2019-2024)
11.11.5 Cepheid Recent Development
11.12 BGI Group
11.12.1 BGI Group Company Detail
11.12.2 BGI Group Business Overview
11.12.3 BGI Group Cytology and HPV Testing Introduction
11.12.4 BGI Group Revenue in Cytology and HPV Testing Business (2019-2024)
11.12.5 BGI Group Recent Development
11.13 Seegene
11.13.1 Seegene Company Detail
11.13.2 Seegene Business Overview
11.13.3 Seegene Cytology and HPV Testing Introduction
11.13.4 Seegene Revenue in Cytology and HPV Testing Business (2019-2024)
11.13.5 Seegene Recent Development
11.14 Daan Gene
11.14.1 Daan Gene Company Detail
11.14.2 Daan Gene Business Overview
11.14.3 Daan Gene Cytology and HPV Testing Introduction
11.14.4 Daan Gene Revenue in Cytology and HPV Testing Business (2019-2024)
11.14.5 Daan Gene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
